Report Type: Therapy Reports
Report Category: Eye Diseases
Report Subcategory: Keratoconjunctivitis Sicca or Dry Eye
Price: 2999.00
Date: July 2021
Keratoconjunctivitis Sicca or Dry Eye Global Market Landscape till 2030: Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Keratoconjunctivitis Sicca or Dry Eye:
Dry eye disease (DED), also known as dry eye syndrome (DES), keratoconjunctivitis sicca (KCS), and keratitis sicca, is a multifactorial disease of the tears and the ocular surface that results in discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface.
Dry eye disease is a common form of ocular surface disease (OSD) and may overlap with other causes of OSD, such as ocular allergy and meibomian gland dysfunction (MGD).

Key Players:
AB2 Bio Ltd
AbbVie Inc
Abilita Bio Inc
Actinobac Biomed Inc
Aerie Pharmaceuticals Inc
Aldeyra Therapeutics Inc
Allegro Ophthalmics LLC
Allergan Inc
Allergan Israel Ltd
Allergan Sales LLC
Allgenesis Biotherapeutics Inc
Allysta Pharmaceuticals Inc
Apidel SA
Ascendia Pharmaceuticals Inc
Auven Therapeutics Development Switzerland Sarl
Aviara Pharmaceuticals Inc
Avixgen Inc
AxeroVision Inc
Azura Ophthalmics Ltd
Beijing Northland Biotech Co Ltd
Bessor Pharma LLC
BRIM Biotechnology Inc
Cambium Medical Technologies LLC
Can-Fite BioPharma Ltd
Cellix Bio Pvt Ltd
Chong Kun Dang Pharmaceutical Corp
Cloudbreak Therapeutics LLC
Dompe Farmaceutici SpA
Elasmogen Ltd
GL Pharm Tech Corp
Glaukos Corp
Glia LLC
GtreeBNT Co Ltd
HanAll Biopharma Co Ltd
Hbm Holdings Ltd
Huons Co Ltd
Huons Global Co Ltd
IACTA Pharmaceuticals Inc
Ildong Pharmaceutical Co Ltd
Inflamalps SA
Intratus Inc
Ipsen SA
IVIEW Therapeutics Inc
Jiangsu Hengrui Medicine Co Ltd
Juvenescence UK Ltd
Kowa Co Ltd
Kukje Pharmaceutical Industry Co Ltd
Kv1.3 Therapeutics
Laboratoires Thea SA
Laboratorios Sophia SA de CV
Lee's Pharmaceutical Holdings Ltd
Link Biologics Ltd
LTT Bio-Pharma Co Ltd
Marinomed Biotech AG
MC2 Therapeutics AS
Melinta Therapeutics Inc
Mimetogen Pharmaceuticals Inc
Mitotech SA
MyX Therapeutics Inc
Nanomerics Ltd
Neuroptika Inc
NicOx SA
Ningbo Xijian Pharmaceutical Technology Co Ltd
NovaCell Technology Inc
Novaliq GmbH
Novartis AG
Novartis AG
Novartis Australia Pty Ltd
Novartis Corp
Novartis Pharmaceuticals Canada Inc
Noveome Biotherapeutics Inc
OccuRx Pty Ltd
Ocular Therapeutix Inc
Oculis SA
Ocumension Therapeutics (Shanghai) Co Ltd
Ocunova LLC
OKYO Pharma Ltd
Otsuka Pharmaceutical Co Ltd
Oyster Point Pharma Inc
Palatin Technologies Inc
Panag Pharma Inc
Panoptes Pharma GesmbH
Pinotbio Inc
Proteris Biotech Inc
Protokinetix Inc
PT Meiji Indonesian Pharmaceutical Industries
Quorum Innovations LLC
Redwood Pharma AB
RegeneRx Biopharmaceuticals Inc
ReGenTree LLC
Reven Pharmaceuticals Inc
RHNanopharmacuticals LLC
RiniSight Inc
Samjin Pharm Co Ltd
Santen Oy
Santen Pharmaceutical China Co Ltd
Santen Pharmaceutical Co Ltd
Santen UK Ltd
Senju Pharmaceutical Co Ltd
Serentrix LLC
Sesen Bio Inc
SIFI Medtech Srl
SIFI SpA
Silk Technologies Ltd
Sinobioway Biomedical Co Ltd
Skye Bioscience Inc
Sol-Gel Technologies Ltd
Stuart Therapeutics Inc
Sun Pharmaceutical Industries Inc
Surface Pharmaceuticals Inc
Surrozen Inc
Sylentis SAU
TaeJoon Pharmaceuticals Co Ltd
Tarsius Pharma Ltd
TearSolutions Inc
Tetra Bio-Pharma Inc
Teva Canada Ltd
TopiVert Ltd
University of Illinois at Chicago
University of Waterloo
Ursapharm Schweiz GmbH
Vanda Pharmaceuticals Inc
Viva Vision Biotech
Xiamen University
Xigen SA
Yuyu Pharma Inc